Xu YP - Search Results

1

circHMGCS1-016 reshapes immune environment by sponging miR-1236-3p to regulate CD73 and GAL-8 expression in intrahepatic cholangiocarcinoma.

Xu YP, Dong ZN, Wang SW, Zheng YM, Zhang C, Zhou YQ, Zhao YJ, Zhao Y, Wang F, Peng R, Tang MC, Bai DS, Huang XY, Guo CY. Xu YP, et al. J Exp Clin Cancer Res. 2021 Sep 15;40(1):290. doi: 10.1186/s13046-021-02095-2. J Exp Clin Cancer Res. 2021. PMID: 34526098 Free PMC article.

2

Treatment of primary isolated extramedullary plasmacytoma of esophagus with endoscopic submucosal dissection.

Zhou Y, Xu X, Xu L, Xu Y, Lu J, Wu D, Wang X, Guo C. Zhou Y, et al. Clin Gastroenterol Hepatol. 2012 Mar;10(3):e21-2. doi: 10.1016/j.cgh.2011.10.038. Epub 2011 Nov 10. Clin Gastroenterol Hepatol. 2012. PMID: 22079849 No abstract available.

3

Salinomycin inhibits proliferation and induces apoptosis of human hepatocellular carcinoma cells in vitro and in vivo.

Wang F, He L, Dai WQ, Xu YP, Wu D, Lin CL, Wu SM, Cheng P, Zhang Y, Shen M, Wang CF, Lu J, Zhou YQ, Xu XF, Xu L, Guo CY. Wang F, et al. Among authors: xu xf, xu l, xu yp. PLoS One. 2012;7(12):e50638. doi: 10.1371/journal.pone.0050638. Epub 2012 Dec 20. PLoS One. 2012. PMID: 23284640 Free PMC article.

4

Overexpression of UHRF2 in intrahepatic cholangiocarcinoma and its clinical significance.

Peng R, Huang X, Zhang C, Yang X, Xu Y, Bai D. Peng R, et al. Onco Targets Ther. 2017 Dec 11;10:5863-5872. doi: 10.2147/OTT.S149361. eCollection 2017. Onco Targets Ther. 2017. PMID: 29270024 Free PMC article.

5

Elevated TRIM44 promotes intrahepatic cholangiocarcinoma progression by inducing cell EMT via MAPK signaling.

Peng R, Zhang PF, Zhang C, Huang XY, Ding YB, Deng B, Bai DS, Xu YP. Peng R, et al. Among authors: xu yp. Cancer Med. 2018 Mar;7(3):796-808. doi: 10.1002/cam4.1313. Epub 2018 Feb 15. Cancer Med. 2018. PMID: 29446253 Free PMC article. Clinical Trial.

6

Role of eIF3C Overexpression in Predicting Prognosis of Intrahepatic Cholangiocarcinoma.

Xu YP, Dong ZN, Zhou YQ, Zhao YJ, Zhao Y, Wang F, Huang XY, Guo CY. Xu YP, et al. Dig Dis Sci. 2022 Feb;67(2):559-568. doi: 10.1007/s10620-021-06878-7. Epub 2021 Feb 12. Dig Dis Sci. 2022. PMID: 33576946

7

High level of CD73 predicts poor prognosis of intrahepatic cholangiocarcinoma.

Xu YP, Zhou YQ, Zhao YJ, Zhao Y, Wang F, Huang XY, Guo CY. Xu YP, et al. J Cancer. 2021 Jun 4;12(15):4655-4660. doi: 10.7150/jca.51038. eCollection 2021. J Cancer. 2021. PMID: 34149929 Free PMC article.

8

Prediction of acute lung injury in severe acute pancreatitis by routine clinical data.

Jia M, Xu X, Zhou S, Liu H, Zhao Y, Xu Y, Tang M, Wu D. Jia M, et al. Eur J Gastroenterol Hepatol. 2023 Jan 1;35(1):36-44. doi: 10.1097/MEG.0000000000002458. Epub 2022 Nov 7. Eur J Gastroenterol Hepatol. 2023. PMID: 36468567

9

In vivo CRISPR screen identifies LTN1 as a novel tumor suppressor ubiquitinating insulin-like growth factor 2 mRNA-binding protein 1 in hepatocellular carcinoma.

Peng R, Cao J, Zhang C, Zhou J, Su BB, Tu DY, Jiang GQ, Jin SJ, Xu YP, Bai DS. Peng R, et al. Among authors: xu yp. Hepatol Commun. 2023 Sep 15;7(10):e0256. doi: 10.1097/HC9.0000000000000256. eCollection 2023 Oct 1. Hepatol Commun. 2023. PMID: 37708447 Free PMC article.

10

MicroRNA-219a-5p suppresses intestinal inflammation through inhibiting Th1/Th17-mediated immune responses in inflammatory bowel disease.

Shi Y, Dai S, Qiu C, Wang T, Zhou Y, Xue C, Yao J, Xu Y. Shi Y, et al. Mucosal Immunol. 2020 Mar;13(2):303-312. doi: 10.1038/s41385-019-0216-7. Epub 2019 Oct 18. Mucosal Immunol. 2020. PMID: 31628427 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

502 results

Search Page

Filters